本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Bolt Biotherapeutics, Inc.

4.62
-0.1500-3.14%
成交量:1.56萬
成交額:7.53萬
市值:886.78萬
市盈率:-0.26
高:5.01
開:4.85
低:4.50
收:4.77
52周最高:9.25
52周最低:3.91
股本:191.94萬
流通股本:144.06萬
量比:0.55
換手率:1.08%
股息:- -
股息率:- -
每股收益(TTM):-17.8500
每股收益(LYR):-17.8500
淨資產收益率:-79.75%
總資產收益率:-27.68%
市淨率:0.33
市盈率(LYR):-0.26

資料載入中...

2023/06/14

重要事件披露

Form 8-K - Current report
2023/05/11

重要事件披露

8-K - Current report
2023/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/20

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/29

重要事件披露

8-K - Current report
2023/03/29

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/29

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/04

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/14

重要事件披露

8-K - Current report
2022/11/10

重要事件披露

8-K - Current report
2022/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/09/30

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/10

重要事件披露

8-K - Current report
2022/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/07/15

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/10

重要事件披露

8-K - Current report
2022/05/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals